Viable head and neck tumor spheroids stimulate in vitro autologous monocyte MCP-1 secretion through soluble substances and CD14/lectin-like receptors

European Archives of Oto-Rhino-Laryngology

Volumn 262, Issue 12, 2005, Pages 953-960

  Olsnes, Carla ^a,b   Heimdal, John Helge ^a,b   Kross, Kenneth W ^a,b   Olofsson, Jan ^a,b   Aarstad, Hans Jørgen ^a,b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

CD14; Monocyte; Monosaccharides; Neoplasms; Spheroids

Indexed keywords

CD14 ANTIBODY; CD14 ANTIGEN; CELL ANTIBODY; DACTINOMYCIN; GALACTOSE; GLUCOSE; LECTIN RECEPTOR; MANNOSE; MONOCYTE CHEMOTACTIC PROTEIN 1; UNCLASSIFIED DRUG;

ARTICLE; CELL STIMULATION; CELL VIABILITY; COCULTURE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; METABOLISM; PRIORITY JOURNAL; PROTEIN SECRETION; SPHEROID CELL; SQUAMOUS CELL CARCINOMA;

ANTIGENS, CD14; AUTOANTIBODIES; CARCINOMA, SQUAMOUS CELL; CHEMOKINE CCL2; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; ENZYME-LINKED IMMUNOSORBENT ASSAY; GALACTOSE; GLUCOSE; HEAD AND NECK NEOPLASMS; HUMANS; LIGANDS; MANNOSE; MONOCYTES; RECEPTORS, MITOGEN; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED;

EID: 29144500358     PISSN: 09374477     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00405-004-0902-1     Document Type: Article

References (44)

1. Young MR (2004) Trials and tribulations of immunotherapy as a treatment option for patients with squamous cell carcinoma of the head and neck. Cancer Immunol Immunother 53:375-382
2. Kerrebijn JD, Balm AJ, Freeman JL, Dosch HM, Drexhage HA (1999) Who is in control of the immune system in head and neck cancer? Crit Rev Oncol Hematol 31:31-53
3. Whiteside TL, Vujanovic NL, Herberman RB (1998) Natural killer cells and tumor therapy. Curr Top Microbiol Immunol 230:221-244
4. Andreesen R, Hennemann B, Krause SW (1998) Adoptive immunotherapy of cancer using monocyte-derived macrophages: rationale, current status, and perspectives. J Leukoc Biol 64:419-426
5. Ferlazzo G, Munz C (2004) NK cell compartments and their activation by dendritic cells. J Immunol 172:1333-1339
6. Burke B, Tang N, Corke KP, Tazzyman D, Ameri K, Wells M, Lewis CE (2002) Expression of HIF-1alpha by human macrophages: implications for the use of macrophages in hypoxia-regulated cancer gene therapy. J Pathol 196:204-212
7. Alexandroff AB, Robins RA, Murray A, James K (1998) Tumor immunology: false hopes - new horizons? Immunol Today 19:247-250
8. Basse PH, Whiteside TL, Herberman RB (2002) Cancer immunotherapy with interleukin-2-activated natural killer cells. Mol Biotechnol 21:161-170
9. Partridge M, Brakenhoff R, Phillips E, Ali K, Francis R, Hooper R, Lavery K, Brown A, Langdon J (2003) Detection of rare disseminated tumor cells identifies head and neck cancer patients at risk of treatment failure. Clin Cancer Res 9:5287-5294
10. Kim SY, Chu KC, Lee HR, Lee KS, Carey TE (1997) Establishment and characterization of nine new head and neck cancer cell lines. Acta Otolaryngol 117:775-784
11. Sacks P (1996) Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck. Cancer Metastasis Rev 15:27-51
12. Fjellbirkeland L, Bjerkvig R, Laerum OD (1995) Tumour fragment spheroids from human non-small-cell lung cancer maintained in organ culture. Virchows Arch 426:169-178
13. Heimdal J, Aarstad HJ, Olofsson J (2000) Monocytes secrete interleukin-6 when co-cultured in vitro with benign or malignant autologous fragment spheroids from squamous cell carcinoma patients. Scand J Immunol 51:271-278
14. Heimdal JH, Olsnes C, Olofsson J, Aarstad HJ (2001) Monocyte and monocyte-derived macrophage secretion of MCP-1 in co-culture with autologous malignant and benign control fragment spheroids. Cancer Immunol Immunother 50:300-306
15. Ward PA, Remold HG, David JR (1970) The production by antigen-stimulated lymphocytes of a leukotactic factor distinct from migration inhibitory factor. Cell Immunol 1:162-174
16. Graves DT, Valente AJ (1991) Monocyte chemotactic proteins from human tumor cells. Biochem Pharmacol 41:333-337
17. Maghazachi AA, Al-Aoukaty A, Schall TJ (1996) CC chemokines induce the generation of killer cells from CD56+ cells. Eur J Immunol 26:315-319
18. Taub DD, Proost P, Murphy WJ, Anver M, Longo DL, van Damme J, Oppenheim JJ (1995) Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. J Clin Invest 95:1370-1376
19. Dawson J, Miltz W, Mir AK, Wiessner C (2003) Targeting monocyte chemoattractant protein-1 signalling in disease. Expert Opin Ther Targets 7:35-48
20. Boisvert WA (2004) Modulation of atherogenesis by chemokines. Trends Cardiovasc Med 14:161-165
21. Brown GD, Taylor PR, Reid DM, Willment JA, Williams DL, Martinez-Pomares L, Wong SY, Gordon S (2002) Dectin-1 is a major beta-glucan receptor on macrophages. J Exp Med 196:407-412
22. Sano H, Hsu DK, Yu L, Apgar JR, Kuwabara I, Yamanaka T, Hirashima M, Liu FT (2000) Human galectin-3 is a novel chemoattractant for monocytes and macrophages. J Immunol 165:2156-2164
23. Cambi A, Figdor CG (2003) Dual function of C-type lectin-like receptors in the immune system. Curr Opin Cell Biol 15:539-546
24. Olsnes C, Heimdal JH, Kross K, Olofsson J, Aarstad HJ (2002) Mechanisms for monocyte activation in co-culture with autologous tumor spheroids. Cell Immunol 219:11-21
25. Gorelik E, Galili U, Raz A (2001) On the role of cell surface carbohydrates and their binding proteins (lectins) in tumor metastasis. Cancer Metastasis Rev 20:245-277
26. Danguy A, Camby I, Kiss R (2002) Galectins and cancer. Biochim Biophys Acta 1572:285-293
27. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC (1990) CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431-1433
28. Heimdal JH, Aarstad HJ, Olsnes C, Olofsson J (2001) Human autologous monocytes and monocyte-derived macrophages in co-culture with carcinoma F-spheroids secrete IL-6 by a non-CD14-dependent pathway. Scand J Immunol 53:162-170
29. Heimdal JH, Aarstad HJ, Aakvaag A, Olofsson J (1997) In vitro T-lymphocyte function in head and neck cancer patients. Eur Arch Otorhinolaryngol 254:318-322
30. Boyum A (1983) Isolation of human blood monocytes with Nycodenz, a new non-ionic iodinated gradient medium. Scand J Immunol 17:429-436
31. Steinsvag SK, Strand M, Berg O, Miaguchi M, Olofsson J (1991) Human respiratory mucosa in a nonadhesive stationary organ culture system. Laryngoscope 101:1323-1331
32. Miller MJ (1987) Sensitivity of RNA synthesis to actinomycin D inhibition is dependent on the frequency of transcription: a mathematical model. J Theor Biol 129:289-299
33. Kacani L, Wurm M, Schennach H, Braun I, Andrle J, Sprinzl GM (2003) Immunosuppressive effects of soluble factors secreted by head and neck squamous cell carcinoma on dendritic cells and T lymphocytes. Oral Oncol 39:672-679
34. Dobrovolskaia MA, Vogel SN (2002) Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes Infect 4:903-914
35. Heidenreich S, Schmidt M, August C, Cullen P, Rademaekers A, Pauels HG (1997) Regulation of human monocyte apoptosis by the CD14 molecule. J Immunol 159:3178-3188
36. Devitt A, Moffatt OD, Raykundalia C, Capra JD, Simmons DL, Gregory CD (1998) Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature 392:505-509
37. Liote F, Boval-Boizard B, Weill D, Kuntz D, Wautier JL (1996) Blood monocyte activation in rheumatoid arthritis: increased monocyte adhesiveness, integrin expression, and cytokine release. Clin Exp Immunol 106:13-19
38. Ueno T, Toi M, Saji H, Muta M, Bando H, Kuroi K, Koike M, Inadera H, Matsushima K (2000) Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin Cancer Res 6:3282-3289
39. Weber KS, Nelson PJ, Grone HJ, Weber C (1999) Expression of CCR2 by endothelial cells: implications for MCP-1 mediated wound injury repair and in vivo inflammatory activation of endothelium. Arterioscler Thromb Vasc Biol 19:2085-2093
40. Nesbit M, Schaider H, Miller TH, Herlyn M (2001) Low-level monocyte chemoattractant protein-1 stimulation of monocytes leads to tumor formation in nontumorigenic melanoma cells. J Immunol 166:6483-6490
41. Seljelid R, Jozefowski S, Sveinbjornsson B (1999) Tumor stroma. Anticancer Res 19:4809-4822
42. Azuma I, Seya T (2001) Development of immunoadjuvants for immunotherapy of cancer. Int Immunopharmacol 1:1249-1259
43. Fukushima M (1996) Adjuvant therapy of gastric cancer: The Japanese experience. Semin Oncol 23:369-378
44. Okamoto M, Ohe G, Oshikawa T, Nishikawa H, Furuichi S, Yoshida H, Matsuno T, Saito M, Sato M (2000) Induction of Th1-type cytokines by lipoteichoic acid-related preparation isolated from OK-432, a penicillin-killed streptococcal agent, Immunopharmacology 49:363-376